查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1465989

自订抗体市场：按类型、按服务、按来源、按研究领域、按最终用户、按应用 - 2024-2030 年全球预测

Custom Antibody Market by Type, Service, Source, Research Area, End Users, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年自订抗体市场规模为7.5586亿美元，预计2024年将达到8.7188亿美元，2030年将达到21.499亿美元，复合年增长率为16.10%。

自订抗体是专门设计和製造的蛋白质，用于特异性结合单一目标分子（称为抗原）。这些抗体经过定制，可识别目标分子上的独特位点并以高特异性结合，使其成为研究、诊断和治疗应用中的宝贵工具。抗体的自订化生产使研究人员能够为新的或研究较少的标靶创建特异性试剂，或创建具有商业上无法获得的所需特性的抗体。由于慢性病和感染疾病在世界各地的流行，需要开发新的诊断和治疗抗体。生物製药公司和学术机构越来越多地投资于研发，支持自订抗体的普及。然而，抗体生产需要复杂的步骤且成本高昂，而且抗体疗法的严格监管要求减缓了市场进入并增加了开发成本。此外，产生具有高特异性和亲和性的抗体仍然具有挑战性，影响了自订抗体应用的有效性。然而，主要企业正在探索人工智慧/机器学习演算法和机器人技术的集成，以简化抗体发现和设计的过程。此外，更有效的融合瘤技术和重组抗体生产的开发，以及靶向药物传输系统和诊断成像的扩大应用，也可能有助于产业成长。

主要市场统计
基准年[2023] 75586万美元
预测年份 [2024] 87188万美元
预测年份 [2030] 21.499 亿美元
复合年增长率（%） 16.10%

对单株抗体应对严重的新需求

单株抗体是由单一 B 细胞克隆产生的相同抗体。这些抗体对单一抗原决定位具有高度特异性，使其可用于研究、诊断和治疗，特别是在癌症、自体免疫疾病和感染疾病的治疗中。多株抗体因其针对单一抗原的特异性和一致性而被选择，这使得它们成为靶向特定分子途径很重要的治疗的理想选择。多株抗体源自于不同的免疫细胞，可辨识抗原上的多个抗原决定位。这使其用途极为广泛，并广泛应用于研究应用，特别是用于检测和精製各种蛋白质。它因其识别多个表位并提高诊断测定灵敏度的能力而受到青睐，使其在研究环境中的蛋白质检测和分析中特别有用。重组抗体是利用重组 DNA 技术在体外生产的。此类别包括单域抗体和片段抗体。其高度可自订的性质使其适用于从研究到治疗用途的广泛应用。它被选用于需要高特异性和重现性且无批次间差异的应用，如多株抗体，并且适用于治疗药物和体外诊断。

最终用户製药和生物技术公司增加对药物开发和诊断的投资

学术和研究机构正在大力投资基础和应用研究计划，这些项目需要自订抗体来获得对生物过程和疾病机制的新见解。高度特异性和可自订的选项优选用于各种研究环境，包括蛋白质体学和基因组学研究。由于预算限制，这些研究机构重视提供技术支援和有竞争力的价格的提供者。委外研发机构(CRO) 充当製药公司和研究活动之间的联络人，代表其客户进行广泛的临床试验和研究计划。 CRO 对自订抗体的需求是高再现性、大批量订单以及满足计划时间表和监管标准的时间效率。 CRO 尤其喜欢能够提供广泛文件和验证服务的供应商。医院和诊所主要使用自订抗体用于诊断目的和个人化医疗。该领域需要高度准确且经过临床检验的抗体，可用于诊断和患者监测。能够在临床试验阶段和监管核准过程中提供强有力支持的供应商受到高度重视。製药和生物技术公司的自订抗体需求占大部分，主要是在药物发现和药物开发过程中。这些公司正在优先考虑可以作为生物标记整合到高通量筛检、治疗应用和临床试验中的抗体。这些公司正在寻找能够大规模提供一致品质的产品、拥有完整的文件并符合监管标准的供应商。

区域洞察

以美国和加拿大为中心的美洲地区以其强大的研究环境而闻名，对自订抗体的需求做出了巨大贡献。该地区强大的生物技术和製药行业正在推动这一需求，学术和商业研究机构都在寻求用于治疗和诊断用途的高品质、特异性抗体。美国最近的专利显示了对新型癌症生物标记和神经退化性疾病的关注，突显了抗体开发领域的持续创新。欧盟（EU）国家拥有先进的医疗保健系统和对生物技术研究强有力的监管支持，创造了有利于研究和开发的环境。欧盟对治疗和诊断分子有严格的规定，为自订抗体的开发提供了标准化和安全的框架。欧盟最近的投资重点是透过创新的抗体解决方案对抗感染疾病和解决自体免疫疾病等慢性病。亚太地区在市场格局中占据着举足轻重的地位，政府资助了多项旨在改善卫生基础设施并增加边缘人群获得诊断和治疗的机会的倡议。中国专注于生物技术创新以及政府对基因组学和蛋白​​质组学研究的投资，创造了高度专业化抗体的需求。日本成熟的製药业优先考虑精准医疗，而印度蓬勃发展的生物技术产业，加上具有成本效益的製造能力，对自订抗体的成长至关重要。

FPNV定位矩阵

FPNV定位矩阵对于评估自订抗体市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对自订抗体市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.自订抗体市场的市场规模和预测是多少？

2.自订抗体市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.自订抗体市场的技术趋势和法规结构是什么？

4.自订抗体市场主要厂商的市场占有率为何？

5. 进入自订抗体市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性感染疾病病率增加
      • 扩展自订抗体在研究、诊断和治疗领域的应用
      • 更多采用抗体工程和个人化治疗的先进技术
    • 抑制因素
      • 开发自订抗体需要大量时间和精力。
    • 机会
      • 政府和私营部门对生命科学和临床研究进行策略性投资
      • 抗体疗法的增加和药物管道的扩展
    • 任务
      • 替代抗体的存在
  • 市场区隔分析
    • 类型：对单株抗体解决严重的新兴需求
    • 最终用户：製药和生技公司增加对药物开发和诊断的投资
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章自订抗体市场：依类型

  • 单株抗体
  • 多株抗体
  • 重组抗体

第七章自订抗体市场：依服务分类

  • 抗体开发
  • 抗体片段化和标记
  • 抗体生产和精製

第 8 章自订抗体市场：依来源分类

  • 老鼠
  • 兔子

第 9 章自订抗体市场研究（按领域）

  • 心血管疾病
  • 免疫学
  • 感染疾病
  • 神经生物学
  • 肿瘤学
  • 干细胞

第 10 章自订抗体市场：依最终用户分类

  • 学术研究所
  • 合约调查机构
  • 医院/诊所
  • 製药和生物技术公司

第十一章自订抗体市场：依应用分类

  • 调查
  • 治疗药物

第十二章美洲客自订抗体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太地区自订抗体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章 欧洲、中东、非洲自订抗体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 丹纳赫将以 57 亿美元收购抗体供应商 Abcam
    • 默克斥资 108 亿美元收购单株抗体
    • Celltrion 和 Genuve 合作开发新的治疗抗体
  • 战略分析和建议

第16章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-46132FF79A8E

[188 Pages Report] The Custom Antibody Market size was estimated at USD 755.86 million in 2023 and expected to reach USD 871.88 million in 2024, at a CAGR 16.10% to reach USD 2,149.90 million by 2030.

Custom antibodies are specialized proteins designed and produced to bind specifically to a single target molecule, known as an antigen. These antibodies are tailor-made to recognize and bind with high specificity to unique sites on target molecules, making them valuable tools in research, diagnostic, and therapeutic applications. The custom production of antibodies allows researchers to generate specific reagents for novel or less-studied targets or to create antibodies with desired properties that are not available off the shelf. The high prevalence and incidences of chronic and infectious diseases worldwide necessitate the development of novel diagnostic and therapeutic antibodies. Heightened investment in research and development by biopharmaceutical companies and academic institutions boosts the proliferation of custom antibodies. However, the intricate processes involved in custom antibody production can be cost-intensive, and stringent regulatory requirements for antibody therapeutics can delay market entry and increase development costs. Moreover, generating antibodies with high specificity and affinity remains challenging, impacting the effectiveness of custom antibody applications. However, key players are exploring the integration of AI/ML algorithms and robotics technologies to ease the process of antibody discovery and design. Furthermore, the development of more efficient hybridoma technology and recombinant antibody production and expanding applications in targeted drug delivery systems and diagnostic imaging could also benefit the growth of the industry.

KEY MARKET STATISTICS
Base Year [2023] USD 755.86 million
Estimated Year [2024] USD 871.88 million
Forecast Year [2030] USD 2,149.90 million
CAGR (%) 16.10%

Type: Emerging need for monoclonal antibodies to tackle severe disease states

Monoclonal antibodies are identical antibodies produced by a single B-cell clone. These antibodies are highly specific to a single epitope, making them valuable in research, diagnostic, and therapeutic contexts, particularly for the treatment of cancers, autoimmune diseases, and infectious diseases. They are chosen for their specificity and consistency in targeting a single antigen and are ideal in therapeutic contexts where targeting a specific molecular pathway is crucial. Polyclonal antibodies are derived from different immune cells and recognize multiple epitopes on an antigen. This makes them extremely versatile and widely used in research applications, particularly for detecting and purifying a wide variety of proteins. They are preferred for their ability to recognize multiple epitopes, enhancing sensitivity in diagnostic assays, and are particularly valuable in research settings for protein detection and analysis. Recombinant antibodies are engineered in vitro using recombinant DNA technology. This category includes single-domain antibodies and fragment antibodies. Their highly customizable nature makes them suitable for a broad range of applications, from research to therapeutic use. They are selected for applications requiring high specificity and reproducibility without the batch-to-batch variation seen in polyclonal antibodies and are suited for therapeutics and in vitro diagnostics.

End Users: Expanding investments by the pharmaceutical & biotechnology companies in drug development and diagnostics

Academic and research institutes significantly invest in basic and applied research projects that require custom antibodies to uncover novel insights into biological processes and disease mechanisms. Their preference leans towards highly specific, customizable options that can be used in various research settings, including proteomics and genomics studies. These entities value providers that offer technical support and competitive pricing due to budget constraints. Contract research organizations (CROs) serve as a bridge between pharmaceutical companies and research activities, conducting a wide array of clinical trials and research projects on behalf of their clients. Their need for custom antibodies revolves around high reproducibility, bulk orders, and time efficiency to meet project timelines and regulatory standards. Notably, CROs prefer vendors that can provide extensive documentation and validation services. Hospitals and clinics primarily utilize custom antibodies for diagnostic purposes and in personalized medicine applications. The demand within this sector is for highly accurate, clinically validated antibodies that can be used in diagnostics and patient monitoring. Suppliers that can offer robust support in clinical trial phases and regulatory approval processes are highly valued. Pharmaceutical and biotechnology companies represent a significant portion of the need for custom antibodies, mainly for drug discovery and development processes. These companies prioritize antibodies that can be integrated into high-throughput screenings, therapeutic applications, and as biomarkers in clinical trials. They seek vendors that are capable of providing large-scale, consistent quality products with thorough documentation and compliance with regulatory standards.

Regional Insights

The Americas, particularly the U.S. and Canada, are known for their robust research environments, contributing significantly to the demand for custom antibodies. The region's strong biotechnology and pharmaceutical sectors drive this need, with both academic and commercial labs seeking high-quality, specific antibodies for therapeutic and diagnostic applications. Recent patents in the U.S. indicate a focus on novel cancer biomarkers and neurodegenerative diseases, highlighting the ongoing innovation in antibody development. European Union (EU) countries boast advanced healthcare systems and strong regulatory support for biotechnology research, fostering a conducive environment for custom antibody development. The presence of stringent regulations for therapeutics and diagnostics molecules in the EU provides a standardized and secure framework for the progression of custom antibodies. Recent EU investments focus on combating infectious diseases and addressing chronic conditions, such as autoimmune disorders, through innovative antibody solutions. The APAC region has emerged as a pivotal landscape in the custom antibody market, supported by several government-funded initiatives to advance the healthcare infrastructure and provide marginalized communities access to diagnostics and therapeutic capabilities. China's focus on biotechnology innovation and government investments in genomics and proteomics research is creating a need for highly specialized antibodies. Japan's well-established pharmaceutical industry prioritizes precision medicine, and India's burgeoning biotechnology sector, coupled with its cost-effective manufacturing capabilities, has proved crucial for the growth of custom antibodies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Custom Antibody Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Custom Antibody Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Custom Antibody Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, ABclonal, Inc., Abgenex Pvt. Ltd., Abnova Corporation, Acrobiosystems Inc., Agilent Technologies, Inc., Alta Bioscience Limited, Bio Basic Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioChain Incorporated, Bioklone Biotech Private Limited, BioLegend, Inc. by PerkinElmer, Inc., Biosynth Ltd., Boster Biological Technology, BTL Biotechno Labs Private Limited, Capralogics, Inc., Cell Signaling Technology, Inc., CiteAb Limited, Creative Biolabs, Creative Diagnostics, CSBio (Shanghai) Ltd., Cusabio Technology LLC, Davids Biotechnologie GmbH, Elabscience, evitria AG by Atlas Antibiodies, GenScript Biotech Corporation, Imgenex India Pvt. Ltd., Innovagen AB, Inotiv, Inc., Kaneka Eurogentec S.A., Laboratory Corporation of America Holdings, Merck KGaA, Metabion International AG, MyBiosource, Inc., OriGene Technologies, Inc., Oy Medix Biochemica AB, Pacific Immunology, PhosphoSolutions, ProMab Biotechnologies, Inc., ProSci Incorporated, ProteoGenix SA, RayBiotech Life, Inc., Rockland Immunochemicals, Inc., Sino Biological, Inc., The Antibody Company, Thermo Fisher Scientific, Inc., and YenZym Antibodies, LLC.

Market Segmentation & Coverage

This research report categorizes the Custom Antibody Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies
  • Service
    • Antibody Development
    • Antibody Fragmentation & Labeling
    • Antibody Production & Purification
  • Source
    • Mice
    • Rabbit
  • Research Area
    • Cardiovascular Diseases
    • Immunology
    • Infectious Diseases
    • Neurobiology
    • Oncology
    • Stem cells
  • End Users
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
  • Application
    • Research
    • Therapeutics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Custom Antibody Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Custom Antibody Market?

3. What are the technology trends and regulatory frameworks in the Custom Antibody Market?

4. What is the market share of the leading vendors in the Custom Antibody Market?

5. Which modes and strategic moves are suitable for entering the Custom Antibody Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic infectious disease worldwide
      • 5.1.1.2. Expanding applications of custom antibody across research, diagnostics, and therapeutics
      • 5.1.1.3. Rising adoption of advanced technologies in antibody engineering and personalized therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Extensive and time consuming to develop custom antibodies
    • 5.1.3. Opportunities
      • 5.1.3.1. Governments and private sector strategically investments in life science and clinical research
      • 5.1.3.2. Increase in therapeutics of antibodies and expansion of drug pipeline
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative antibodies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Emerging need for monoclonal antibodies to tackle severe disease states
    • 5.2.2. End Users: Expanding investments by the pharmaceutical & biotechnology companies in drug development and diagnostics
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Custom Antibody Market, by Type

  • 6.1. Introduction
  • 6.2. Monoclonal Antibodies
  • 6.3. Polyclonal Antibodies
  • 6.4. Recombinant Antibodies

7. Custom Antibody Market, by Service

  • 7.1. Introduction
  • 7.2. Antibody Development
  • 7.3. Antibody Fragmentation & Labeling
  • 7.4. Antibody Production & Purification

8. Custom Antibody Market, by Source

  • 8.1. Introduction
  • 8.2. Mice
  • 8.3. Rabbit

9. Custom Antibody Market, by Research Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Immunology
  • 9.4. Infectious Diseases
  • 9.5. Neurobiology
  • 9.6. Oncology
  • 9.7. Stem cells

10. Custom Antibody Market, by End Users

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Hospitals & Clinics
  • 10.5. Pharmaceutical & Biotechnology Companies

11. Custom Antibody Market, by Application

  • 11.1. Introduction
  • 11.2. Research
  • 11.3. Therapeutics

12. Americas Custom Antibody Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Custom Antibody Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Custom Antibody Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Danaher to Buy Antibody Supplier Abcam for USD 5.7 Billion
    • 15.3.2. Merck to Develop mAb Through USD 10.8 Billion Acquisition
    • 15.3.3. Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies
  • 15.4. Strategy Analysis & Recommendation

16. Competitive Portfolio

  • 16.1. Key Company Profiles
  • 16.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CUSTOM ANTIBODY MARKET RESEARCH PROCESS
  • FIGURE 2. CUSTOM ANTIBODY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CUSTOM ANTIBODY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 28. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CUSTOM ANTIBODY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 338. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 349. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 350. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 351. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 352. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 353. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 354. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 355. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 358. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 359. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 360. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 361. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 362. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 363. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 364. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 365. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 366. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 367. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 368. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 369. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 370. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 371. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLI